BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 03/04/2024

FDA Announces Draft Guidance for Oxymetazoline Hydrochloride

The FDA is releasing a draft guidance document outlining product-specific recommendations for the development of oxymetazoline hydrochloride ophthalmic solution, including bioequivalence studies to support ANDA submissions.

Source: Federal Register — Food and Drug AdministrationOpen original release →